CD47 antibodies (Synthon Biopharmaceuticals/Sanquin Blood Supply Foundation)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD47 antibodies (Synthon Biopharmaceuticals/Sanquin Blood Supply Foundation)
Drug Alias NameCD47 checkpoint inhibitor (Synthon Biopharmaceuticals/Sanquin Blood Supply Foundation)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanquin Blood Supply Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyntarga BVSanquin Blood Supply Foundation
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A